Bringing the fundamentals into focus…
Back to Royalty Pharma plc
How Royalty Pharma plc stacks up
RPRX · against 71 other Healthcare companies of similar size
Overall
50/ 100
Below the middle of the pack.
Ranked #49 of 72 · scores higher than 31% of peers
Bars: peers in each 10-point band of the overall score21 peers with an overall score of 50–59, including RPRX · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around RPRX| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 23.8B USD | 84 | 82 | 82 | 98 | 0 / 2 | |
| 2 | 56.7B USD | 79 | 42 | 96 | 93 | 0 / 2 | |
| 3 | 193.6B HKD (≈$24.8B) | 78 | 64 | 74 | 97 | 0 / 2 | |
| 4 | 4.61T JPY (≈$31.3B) | 76 | 93 | 89 | 87 | 1 / 2 | |
| 5 | 534.1B HKD (≈$68.4B) | 75 | 72 | 76 | 96 | 1 / 2 | |
| 45 | 58.6B USD | 52 | 58 | 56 | 85 | 2 / 2 | |
| 45 | 28.7B USD | 52 | 63 | 55 | 65 | 2 / 2 | |
| 48 | 64.8B EUR (≈$71.3B) | 51 | 67 | 29 | 74 | 1 / 2 | |
| 49 | 36.4B USD | 50 | 74 | 39 | 70 | 2 / 2 | |
| 49 | 38.4B USD | 50 | 50 | 38 | 80 | 2 / 2 | |
| 51 | 50.2B USD | 49 | 64 | 58 | 50 | 2 / 2 | |
| 51 | 133.4B BRL (≈$24.0B) | 49 | 67 | 50 | 57 | 2 / 2 | |
| 51 | 34.0B USD | 49 | 51 | 45 | 97 | 2 / 2 | |
| 54 | 95.4B AUD (≈$62.9B) | 48 | 42 | 77 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score